Total Voting Rights

GlaxoSmithKline PLC
01 February 2007



             Total Voting Rights and Capital as at 31 January 2007


In conformity with the Disclosure and Transparency Rules 5.6.1R, GlaxoSmithKline
plc ("the Company") hereby notifies the market of the following:

The Company's issued share capital as at 31 January 2007 consists of
5,997,132,010 Ordinary shares of 25p each with voting rights, of which
247,572,678 Ordinary shares are held in Treasury.

Therefore, the total number of voting rights in the Company is 5,749,559,332.
This figure may be used by shareholders as the denominator for the calculations
by which they will determine if they are required to notify their interest in,
or a change to their interest in, the Company under the Financial Services
Authority's Disclosure and Transparency Rules.



S M Bicknell
Company Secretary


1 February 2007


                      This information is provided by RNS
            The company news service from the London Stock Exchange